Physician profile
Gary J Brauner
NPI 1730149501
$1,108.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $137 · 2022: $252 · 2023: $258 · 2024: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $239.57 | 2019-2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $227.70 | 2021-2024 | Libtayo |
| Amgen INC. | $157.04 | 2021-2023 | Otezla |
| Novartis Pharmaceuticals Corporation | $140.23 | 2019-2023 | |
| Lilly USA, LLC | $134.49 | 2022 | |
| Abbvie INC. | $95.96 | 2023 | |
| Arcutis Biotherapeutics, INC. | $28.70 | 2023 | |
| Aroa Biosurgery Incorporated | $20.11 | 2023 | |
| Genzyme Corporation | $19.43 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2023 | Spevigo |
| Pfizer INC. | $14.78 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Brauner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.